Renal function trajectory is more important than chronic kidney disease stage for managing patients with chronic kidney disease

American Journal of Nephrology

Volumn 36, Issue 1, 2012, Pages 1-10

  Rosansky, Steven J ^a,b  

^a WJB Dorn VA Medical Center   (United States)

^b NONE   (United States)

Author keywords

Chronic kidney disease; Creatinine clearance; Diabetes mellitus; End stage renal disease; Hemodialysis; Kidney failure; Proteinuria

Indexed keywords

ALKALI; ANGIOTENSIN RECEPTOR ANTAGONIST; BENAZEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; IRBESARTAN; LOSARTAN;

ACUTE KIDNEY FAILURE; ALBUMINURIA; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; COMORBIDITY; CREATININE BLOOD LEVEL; DEATH; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSIS; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEINURIA; RENAL PROTECTION; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; RISK REDUCTION; TREATMENT INDICATION; TREATMENT PLANNING; VASCULAR ACCESS;

EID: 84862212569     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000339327     Document Type: Review

References (93)

1. Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenlid K, Orth SR: Combining GFR and al-buminuria to classify CKD improves predic-tion of ESRD. J Am Soc Nephrol 2009; 20: 1069-1077.
2. Froissart M, Rossert R, Jacquot, C, Paillard M, Houillier P: Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 2005; 16: 763-773. (Pubitemid 41725113)
3. Hois R, Bevc S, Ekart R, et al: Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impair-ment of kidney function. Nephrol Dial Transplant 2006; 21:1855-1862. (Pubitemid 43985713)
4. Mitch WE, Walser M, Buffington GA, Le-mann J Jr: A simple method of estimating progression of chronic renal failure. Lancet 1976;ii:1326-1328.
5. Foley RN, Murray AM, Li S, et al: Chronic kidney disease and the risk for cardiovascu-lar disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489-495.
6. Al-Aly Z, Zeringue A, Fu J, et al: Rate of kid-ney function decline associates with mortal-ity. J Am Soc Nephrol 2010; 21: 1961-1969.
7. Rifkin DE, Shlipak MG, Katz R: Rapid kid-ney function decline and mortality risk in older adults. Arch Intern Med 2008; 168: 2212-2218.
8. Ishani A, Nelson D, Clothier B, et al: The magnitude of acute serum creatinine in-crease after cardiac surgery and the risk of chronic kidney disease, progression of kid-ney disease, and death. Arch Intern Med 2011; 171:226-233.
9. Murthy K, Stevens LA, Stark PC Levey AS: Variation in the serum creatinine assay cali-bration: a practical application to glomerular filtration rate estimation. Kidney Int 2005; 68:1884-1887. (Pubitemid 43169935)
10. Coresh J Astor B: Kidney function in the el-derly. Ann Intern Med 2006; 145:299-301.
11. Grootendorst DC, Michels WM, Richardson JD, et al; for the NECOSAD Study Group: The MDRD formula does not reflect GFR in ESRD patients. Nephrol Dial Transplant 2011; 26: 1932-1937.
12. Beddhu S, Samore MH, Roberts MS, et al: Creatinine production, nutrition, and glo-merular filtration rate estimation. J Am Soc Nephrol 2003; 14: 1000-1005. (Pubitemid 36359281)
13. 2 . Am J Kidney Dis 2010; 56: 486-495.
14. Fontseré N, Bonal J, Navarro M, et al: A com-parison of prediction equations for estimat-ing glomerular filtration rate in adult pa-tients with chronic kidney disease stages 4-5, effect of nutritional status and age. Nephron Clin Pract 2006; 104:c160-c168. (Pubitemid 44875773)
15. Garcia-Naveiro R, Rodriguez-Carmona A, Pérez-Fontán M: Agreement between two routine methods of estimation of glomerular filtration rate in patients with advanced and terminal chronic renal failure. Clin Nephrol 2005; 64:271-280. (Pubitemid 41448429)
16. Levey AS, Gassman JJ, Hall PM, Walker WG; for the MDRD Study Group: Assessing the progression of renal disease in clinical stud-ies: effects of duration of follow-up and re-gression to the mean. J Am Soc Nephrol 1991; 1:1087-1094.
17. Eriksen BO, Ingebretsen OC: In chronic kid-ney disease staging the use of the chronicity criterion affects prognosis and the rate of progression. Kidney Int 2007; 72:1242-1248. (Pubitemid 350059657)
18. Anderson AH: Screening for proteinuria: a tool for predicting rapid declines in kidney function? J Am Soc Nephrol 2011; 22:1580-1583.
19. Fontseré N, Salinas I, Bonal J, et al: Are pre-diction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients? Nephrol Dial Trans-plant 2006; 21:2152-2158. (Pubitemid 44295039)
20. Xie D, Joffe MM, Brunelli SM, et al: A com-parison of change in measured and estimat-ed glomerular filtration rate in patients with nondiabetic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1332-1338.
21. Wang X, Lewis J, Appel L, et al: Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal stud-ies of kidney disease. J Am Soc Nephrol 2003; 14: 1000-1005.
22. Lewis J, Greene T, Appel L, et al; for the AASK Study Group; A comparison of iothal-amate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR de-cline in the African-American study of kid-ney disease and hypertension. J Am Soc Nephrol 2004; 15, 3175-3183. (Pubitemid 39578850)
23. Clark WF, Macnab JJ, Sontrop JM, et al: Dip-stick proteinuria as a screening strategy to identify rapid renal decline. J Am Soc Nephrol 2011; 22:1729-1736.
24. Levin A, Djurdjie O, Beaulieu M, Er L: Vari-ability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 2008; 52:661-671.
25. Eriksen BO Ingebretsen OC: The progres-sion of chronic kidney disease: a 10-year population-based study of the effects of gen-der and age. Kidney Int 2006; 69: 375-382. (Pubitemid 43323090)
26. Rottey S, Vanholder R, De Schoenmakere G, Lameire N Progression of renal failure in pa-tients with compromised renal function is not always present: evaluation of underlying disease. Clin Nephrol 2000; 54:1-10. (Pubitemid 30456798)
27. Hunsickler LG, Adler S, Caggiula A, et al: Predictors of the progression of renal disease in the modification of diet in renal disease study. Kidney Int 1997; 51: 1908-1919. (Pubitemid 27252762)
28. Perkins RM, Bucalord JD, Kirchner HL, Ashouian N, Hartle JE, Yahya T: GFR decline and mortality risk among patients with chronic kidney disease. Clin J Am Soc Nephrol 2011; 6:1879-1886.
29. Lindeman RD, Tobin J, Shock NW: Longitu-dinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33: 278.
30. Conway B, Webster A, Ramsay G, et al: Pre-dicting mortality and uptake of renal re-placement therapy in patients with stage 4 chronic kidney disease. Nephrol Dial Trans-plant 2009; 24: 1930-1937.
31. O'Hare AM, Choi AI, Bertenthal D, et al: Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 2007; 18: 2758-2765. (Pubitemid 47531203)
32. Evan M, Fryzek JP, Elinder C-G, et al: The natural history of chronic renal failure: re-sults from and unselected, population-based, inception cohort in Sweden. Am J Kidney Dis 2005; 46:863-870. (Pubitemid 41505460)
33. John R, Webb M, Young A, Stevens PE: Un-referred chronic kidney disease: a longitudi-nal study. Am J Kidney Dis 2004; 43:825-835. (Pubitemid 38529620)
34. Imai E, Horio M, Yamagata K, et al: Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res 2008; 31:433-441. (Pubitemid 351597496)
35. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 2000; 11:319-329. (Pubitemid 30064855)
36. Jafar TH, Schmid CH, Stark PC, et al: The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. Nephrol Dial Transplant 2003; 18: 2047-2053. (Pubitemid 37220310)
37. Levey AS, de Jong PE, Coresh J, et al: The definition, classification, and prognosis of chronic kidney disease: a KDIGO controver-sies conference report. Kidney Int 2011; 80: 17-28.
38. Gansevoort RT, Matsushita K, van der Velde M, et al: Lower estimated GFR and higher albuminuria are associated with adverse kid-ney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 2011; 80:93-104.
39. Hemmelgarn BR, Manns BJ, Lloyd A, et al: Relation between kidney function, protein-uria, and adverse outcomes. JAM A 2010; 303: 423-429.
40. Lea J, Greene T, Herbert L, et al: The relation-ship between magnitude of proteinuria re-ductiona and risk of end-stage renal disease. Arch Intern Med 2005; 165:947-953.
41. Keane WF, Brenner BM, de Zeeuw D, et al: The risk of developing end-stage renal dis-ease in patients with type 2 diabetes and ne-phropathy: the RENAAL study. Kidney Int 2003; 63:1499-1507. (Pubitemid 36350016)
42. Peralta CA, Katz R, Deboer I, et al: Racial and ethnic differences in kidney function decline among persons without chronic kidney dis-ease. J Am Soc Nephrol 2011; 22: 1327-1334.
43. Barbour SJ, Schachter M, Er L, Djurdjev O, Levin A: A systematic review of ethnic dif-ferences in the rate of renal progression in CKD patients. Nephrol Dial Transplant 2010; 25:2422-2430.
44. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J: End-stage renal disease in African-American and white men. JAMA 1997; 277:1293-1298. (Pubitemid 27194353)
45. McClellan WM, Warnock DG, Judd S, et al: Albuminuria and racial disparities in the risk for ESRD. J Am Soc Nephrol 2011; 22: 1721-1728.
46. Menon V, Kopple JD, Wang X, et al: Effect of a very low-protein diet on outcomes: long-term follow-up of the modification of diet in renal disease (MDRD) study. Am J Kidney Dis 2009; 53: 208-217.
47. Halbesma N, Bakker SJ, Jansen DF, et al: High protein intake associates with cardio-vascular events but not with loss of renal function. J Am Soc Nephrol 2009; 20:1797-1804.
48. Hallan SI Orth SR: Smoking is a risk factor in the progression to kidney failure. Kidney Int 2011; 80: 516-523.
49. Rosansky SJ, Hoover D, King L Gibson J: The association of blood pressure levels and change in renal function in hypertensive and non-hypertensive subjects. Arch Int Med 1990; 150:2073-2076. (Pubitemid 20348357)
50. Wright Jr JT, Bakris G, Greene T, et al: Effect of blood pressure lowering and antihyper-tensive drug class on progression of hyper-tensive kidney disease. JAMA 2002; 288: 2421-2431. (Pubitemid 35340538)
51. Appel LJ, Wright JT, Greene T, et al: Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med 2010; 363:918-929.
52. Jafar TH, Stark PC, Schmid CH, et al: Pro-gression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition, a patient-level meta-analysis. Ann Intern Med 2003; 139: 244-252.
53. ACCORD Study Group: Effects of intensive blood-pressure control in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.
54. Kent DM, Jafar TH, Hayward RA, et al: Pro-gression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol 2007; 18: 1959-1965.
55. Lewis EJ, Hunsicker LG, Clarke WR, et al: Renoprotective effect of the angiotensin-re-ceptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860.
56. Brenner BM, Cooper ME, de Zeeuw D, et al: Effects of losartan on renal and cardiovascu-lar outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
57. Bakris GL: Slowing nephropathy progres-sion: focus on proteinuria reduction. Clin J Am Soc Nephrol 2008; 3:S3-S10.
58. Thomas MC, Jerums G, Salamandris C, MacIssac R, Panagiotopoulos S, Cooper ME, MDNSG Study Group: Increased tubular or-ganic ion clearance following chronic ACE inhibition in patients with type 1 diabetes. Kidney Int 2005; 67:2494-2499. (Pubitemid 41623415)
59. Kunz R, Friedrich C, Wolbers M, Mann JFE: Meta-analysis: effects of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease. Ann Intern Med 2008; 148: 30-48. (Pubitemid 351688350)
60. Mann JFE, Schmieder RE, McQueen M, et al: Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 2008; 372: 547-553.
61. Ruggenenti P, Perna A, Remuzzi G; on behalf of the investigators of the GISEN group: Re-tarding progression of chronic renal disease: the neglected issue of residual proteinuria. Kidney Int 2003; 63: 2254-2261. (Pubitemid 36605839)
62. Hou FF, Xie D, Zhang X, et al: Renoprotec-tion of optimal antiproteinuric doses (ROAD) study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency. J Am Soc Nephrol 2007; 18: 1889-1898. (Pubitemid 46870325)
63. Holtkamp FA, de Zeeuw D, Thomas MC, et al: An acute fall in estimated glomerular fil-tration rate during treatment with losartan predicts a slower decrease in long-term renal function. Kidney Int 2011; 80:282-287.
64. De Boer IH, Sun W, Cleary PA, et al: Inten-sive diabetes therapy and glomerular filtra-tion rate in type 1 diabetes. N Engl J Med 2011; 365:2366-2376.
65. Forsblom C, Harjutsalo V, Thorn LM: Compteting-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 2011; 22: 537-544.
66. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH: Progression of diabetic ne-phropathy. Kidney Int 2001; 59: 702-709.
67. The ADVANCE Collaborative Group: Inten-sive blood glucose control and vascular out-comes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
68. Ismail-Beigi F, Craven T, Banerji MA, et al: Effect of intensive treatment of hyperglycae-mia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD ran-domised trial. Lancet 2010; 376: 419-430.
69. Sahni V, Rosa RM, Batlle D: Potential bene-fits of alkali therapy to prevent GFR loss: time for a palatable 'solution' for the manage-ment of CKD. Kidney Int 2010; 78:1065-1067.
70. De Brito-Ashurst I, Varagunam M, Raftery MJ, Yagoob MM: Bicarbonate supplementa-tion slows progression of CDK and improves nutritional status. J Am Soc Nephrol 2009; 20:2075-2084.
71. Bayliss EA, Bhardwaja B, Ross C, Beck A, La-nese DM: Multidisciplinary team care may slow the rate of decline in renal function. Clin J Am Soc Nephrol 2011; 6:704-710.
72. Barrett BJ, Garg AX, Goeree R, et al: A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trail. Clin J Am Soc Nephrol 2011; 6:1241-1247.
73. Wu V, Huang T-M, Lai C-F, et al: Acute-on-chronic kidney injury at hospital discharge is associated with long-term dialysis and mor-tality. Kidney Int 2011; 80:1222-1230.
74. Hsu CY, Ordoñez JD, Chertow GM, Fan D, McCulloch CE, Go AS: The risk of acute re-nal failure in patients with chronic kidney disease. Kidney Int 2008; 74:101-107. (Pubitemid 351841887)
75. Ishani A, Xue JL, Himmelfarb J, et al: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2009; 20: 223-228.
76. Onuigbo MAC: Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD. Renal Failure 2010; 32:964-958.
77. Seabra VF, Balk EM, Liangos O, Sosa MA, Cendoroglo M, Jaber BL: Timing of renal re-placement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis 2008; 52:272-284. (Pubitemid 351978141)
78. Rosansky SJ, Glassock RJ, Clark WF: Early start of dialysis: a critical review. Clin J Am Soc Nephrol 2011; 6: 1222-1228.
79. Rosansky SJ, Hardin JW, Richards F, et al: Relationship between outpatient AKI', pro-teinuria, diagnosis diabetes, race and rate of decline in renal function, nine years prior to dialysis initiation. 2011;http://www.asn-on- line.org.
80. Rosansky SJ, Hardin JW, Richards F, et al: The relationship of urine proteinuria to outpatient AKI' and renal progression. 2011;http://www.asn- online.org.
81. Jones C, Roderick P, Harris S, Rogerson M: Decline in kidney function before and after nephrology referral and the effect on surviv-al in moderate to advanced chronic kidney disease. Nephrol Dial Transplant 2006; 21: 2133-2143. (Pubitemid 44313384)
82. Ambrogi V, Thilly N, Boini S, Virion J-M: Patterns and predictors of kidney function decline in the last year prior to dialsys. Neph-ron Clin Pract 2009; 111:c95-c101.
83. Tattersall J, Dekker F, Heimbürger O: When to start dialysis: updated guidance following publication of the initiating dialysis early and late (IDEAL) study. Nephrol Dial Trans-plant 2011; 26: 2082-2086.
84. Tangri NA, Stevens LA, Griffith J: A predic-tive model for progression of chronic kidney disease to kidney failure. JAMA 2011; 305: 1553-1559.
85. Shlipak MG, Katz R, Kestenbaum B, et al: Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol 2009; 20: 2625-2630.
86. Matsushita K, Selvin E, Bash LD, Frances-chini N, Astor BC, Coresh J: Change in esti-mated GFR associates with coronary heart disease and mortality. Clin J Am Soc Nephrol 2009; 20: 2617-2624.
87. Hsu CY, Chertow GM, McCulloch CE, Fan D, Ordoñez Go AS: Nonrecovery of kidney function and death after acute on chronic re-nal failure. Clin J Am Soc Nephrol 2009; 4: 891-898.
88. Jaar BG, Khatib R, Plantinga L, Boulware, LE, Powe NR: Principles of screening for chronic kidney disease. Clin J Am Soc Nephrol 2008; 3:601-609.
89. Demoulin N, Beguin C, Labriola L, Jadoul M: Preparing renal replacement therapy in stage 4 CKD patients referred to nephrolo-gists: a difficult balance between futility and insufficiency. A cohort study of 386 patients followed in Brussels. Nephrol Dial Trans-plant 2011; 26: 220-226.
90. Alves TP, Wang X, Wright JT Jr, et al: Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclero-sis. J Am Soc Nephrol 2010; 21: 1361-1369.
91. Obi Y, Kimura R, Nagasawa Y, et al: Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a re-ferred cohort. Clin J Am Nephrol 2010; 5: 1558-1565.
92. O'Hare AM, Bertenthal D, Walter LC, et al: When to refer patients with chronic kidney disease for vascular access surgery: should age be a consideration? Kidney Int 2007; 71: 555-561. (Pubitemid 46398678)
93. Vachharajani TJ, Moossavi S, Jordan JR Vachharajani V, Freedman BI, Burkart JM: Re-evaluating the fistula first initiative in octogenarians on hemodialysis. Clin J Am Soc Nephrol 2011; 6:663- 1667.